Search

everythinglearnresearchcommunity

for

Search:↓

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Using Mark Cuban Cost Plus Drug Company can save money on men's health medications compared to Medicare.

Drug repurposing offers faster, cheaper drug development but faces challenges like safety, ethics, and funding.

The same drug is priced differently based on its use.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Different drug doses approved in Japan and the U.S. are not mainly due to different clinical responses, and ethnic factors should be considered in setting drug doses.

Old drugs can be used for new treatments, saving time and money, but there are challenges like needing more evidence and legal concerns.

The conclusion is that the increasing use of drugs for lifestyle reasons is a complex issue influenced by corporate profit, consumer behavior, and the medicalization of everyday life, with potential negative effects on personal well-being.

UK courts and the European Patent Office are now more open to granting patents for new dosage regimes.

Using electronic health records can help identify drug side effects but has some limitations.

Redefining drug dosages is crucial when repurposing them for new uses.

Data-driven methods can effectively identify existing drugs for new uses, especially in cancer, infections, and respiratory diseases.

Biosimilars lower costs but don't significantly improve access.

Public health decisions should rely on independent trials, not biased literature.

Proscar and Propecia, two drugs with the same ingredient but different dosages, have different prices, showing price discrimination in the pharmaceutical industry.

Drug repurposing finds new uses for existing drugs, saving time and money.

The review concludes that pharmacists should clearly define their product as more than medication, including their knowledge and services, to effectively communicate their value.

New drugs face challenges due to limited evidence, and safety updates are advised for some existing medications.

The document concludes that computational methods using networks and various data can improve the process of finding new uses for existing drugs.

Drug repositioning can save time and money but needs more support.

Government action is needed to address high prescription drug prices.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

The article concludes that recent legal rulings have strengthened the protection of pharmaceutical patents against generic competition.

The document shows the state of pharmaceutical patents as of 1999, focusing on treatments for various diseases.

Reviewers criticized the study's methods and suggested focusing on drug mechanisms instead of repositioning due to social media data quality concerns.

The research predicted the effectiveness of Ayurvedic hair care products by calculating their Drug Efficacy Indices.

Finding new uses for existing drugs is promising and can lead to safer, more effective medicines.

Switching to generic drugs is necessary but faces communication and information challenges.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Monitoring new epilepsy drugs after they're sold is crucial to find rare and long-term side effects that initial tests might miss.